Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance.

Nafise GhalandariHubertina Jmj CrijnsRadboud Jem DolhainJohanna Mw HazesEugene P van Puijenbroek

Published in: Lupus (2022)

The positive results of our study are supportive for the continuation of belimumab during pregnancy. Since the analysis is based on spontaneous reports/retrospective data, additional studies are needed to confirm the results.

Keyphrases

systemic lupus erythematosus
electronic health record
cross sectional
emergency department
stem cells
big data
machine learning
adverse drug
bone marrow
case control
deep learning